Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue

American Journal of Veterinary Research

Volumn 71, Issue 10, 2010, Pages 1237-1245

  Toupadakis, Chrisoula A ^a   Wong, Alice ^a   Genetos, Damian C ^a   Cheung, Whitney K ^b   Borjesson, Dori L ^a   Ferraro, Gregory L ^a   Galuppo, Lawrence D ^a   Leach, J Kent ^b   Owens, Sean D ^a   Yellowley, Clare E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTEOMODULIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL ISOLATION; CELL MEMBRANE POTENTIAL; ENZYME ACTIVITY; HORSE; MESENCHYMAL STEM CELL; NEWBORN; NONHUMAN; OSTEOBLAST; SERUM; STAINING; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; FETAL BLOOD; HORSES; MESENCHYMAL STEM CELLS; OSTEOGENESIS; UMBILICAL CORD;

ANIMALIA; BOVINAE; EQUIDAE;

EID: 77958605841     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.10.1237     Document Type: Article

References (51)

1. Boyd HB, Lipinski SW, Wiley JH. Observations on non-union of the shafts of the long bones, with a statistical analysis of 842 patients. J Bone Joint Surg Am 1961;43:159-168.
2. De Buren N. Causes and treatment of non-union in fractures of the radius and ulna. J Bone Joint Surg Br 1962;44:614-625.
3. Nolte DM, Fusco JV, Peterson ME. Incidence of and predisposing factors for nonunion of fractures involving the appendicular skeleton in cats: 18 cases (1998-2002). J Am Vet Med Assoc 2005;226:77-82.
4. Perumal V, Roberts C. Factors contributing to non-union of fractures. J Orthop Traumatol 2007;21:258-261.
5. Richards M, Huibregtse BA, Caplan AI, et al. Marrow-derived progenitor cell injections enhance new bone formation during distraction. J Orthop Res 1999;17:900-908.
6. Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003;121:368-374.
7. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
8. Fortier LA, Nixon AJ, Williams J, et al. Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187.
9. Arnhold SJ, Goletz I, Klein H, et al. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res 2007;68:1095-1105.
10. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
11. Vidal MA, Kilroy GE, Lopez MJ, et al. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 2007;36:613-622.
12. Hoynowski SM, Fry MM, Gardner BM, et al. Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun 2007;362:347-353.
13. Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675.
14. Koch TG, Heerkens T, Thomsen PD, et al. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol [serial online]. 2007;7:26. Available at: www.biomed-central.com/1472-6750/7/26. Accessed Jul 9, 2010.
15. Schuh EM, Friedman MS, Carrade DD, et al. Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood. Am J Vet Res 2009;70:1526-1535.
16. Reed SA, Johnson SE. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 2008;215:329-336.
17. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764.
18. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
19. Vaes BL, Dechering KJ, Feijen A, et al. Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 2002;17:2106-2118.
20. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.
21. Lee CC, Ye F, Tarantal AF. Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev 2006;15:209-220.
22. Worster AA, Nixon AJ, Brower-Toland BD, et al. Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 2000;61:1003-1010.
23. Yoshimura K, Shigeura T, Matsumoto D, et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006;208:64-76.
24. Halvorsen YD, Bond A, Sen A, et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism 2001;50:407-413.
25. Bartholomew S, Owens SD, Ferraro GL, et al. Collection of equine cord blood and placental tissues in 40 thoroughbred mares. Equine Vet J 2009;41:724-728.
26. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
27. Vidal MA, Kilroy GE, Johnson JR, et al. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 2006;35:601-610.
28. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
29. Carstanjen B, Desbois C, Hekmati M, et al. Successful engraftment of cultured autologous mesenchymal stem cells in a surgically repaired soft palate defect in an adult horse. Can J Vet Res 2006;70:143-147.
30. Smith RK, Korda M, Blunn GW, et al. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35:99-102.
31. Koerner J, Nesic D, Romero JD, et al. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:1613-1619.
32. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005;13:845-853.
33. Panepucci RA, Siufi JL, Silva WA Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004;22:1263-1278.
34. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301.
35. Kuznetsov SA, Krebsbach PH, Satomura K, et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;12:1335-1347.
36. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263-272.
37. Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000;97:3213-3218.
38. Peterson B, Zhang J, Iglesias R, et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005;11:120-129.
39. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006;98:538-554.
40. O'Donoghue K, Fisk N. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 2004;18:853-875.
41. O'Donoghue K, Chan J. Human fetal mesenchymal stem cells. Curr Stem Cell Res Ther 2006;1:371-386.
42. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 1997;79:1699-1709.
43. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004;9:747-756.
44. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004;95(suppl 1):S29-S33.
45. Katritsis DG, Sotiropoulou PA, Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005;65:321-329.
46. Sotiropoulou PA, Perez SA, Salagianni M, et al. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006;24:1409-1410.
47. Berger MG, Veyrat-Masson R, Rapatel C, et al. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006;24:2888-2890.
48. Dimarakis I, Levicar N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006;24:1407-1408.
49. Eslaminejad MB, Rouhi L, Arabnajafi M, et al. Rat marrow-derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum. Cell Biol Int 2009;33:607-616.
50. Stute N, Holtz K, Bubenheim M, et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004;32:1212-1225.
51. Moore SG, Dawson KL. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 1990;175:219-223.